부산대학교 도서관

Floriana De Angelis; Peter Connick; Richard A Parker; Domenico Plantone; Anisha Doshi; Nevin John; Jonathan Stutters; David MacManus; Ferran Prados; Ian Marshall; Bhavana Solanky; Rebecca S Samson; Frederik Barkhof; Sebastien Ourselin; Marie Braisher; Moira Ross; Gina Cranswick; Sue H Pavitt; Sharmilee Gnanapavan; Gavin Giovannoni; Claudia AM Gandini Wheeler-Kingshott; Clive Hawkins; Basil Sharrack; Roger Bastow; Christopher J Weir; Nigel Stallard; Siddharthan Chandran; Jeremy Chataway

Efficacy and Mechanism Evaluation, Vol 7, Iss 3 (2020)
De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, Macmanus, D, Prados, F, Marshall, I, Solanky, B, Samson, R S, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Gnanapavan, S, Giovannoni, G, Wheeler-kingshott, C A G, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J, Stallard, N, Chandran, S & Chataway, J 2020, ' Amiloride, fluoxetine or riluzole to reduce brain volume loss in secondary progressive multiple sclerosis: the MS-SMART four-arm RCT ', Efficacy and Mechanism Evaluation, vol. 7, no. 3, pp. 1-72 . https://doi.org/10.3310/eme07030

Chataway, J; De Angelis, F; Connick, P; Parker, RA; Plantone, D; Doshi, A; John, N; Stutters, J; MacManus, D; Prados Carrasco, F; Barkhof, F; Ourselin, S; Braisher, M; Ross, M; Cranswick, G; Pavitt, SH; Giovannoni, G; Gandini Wheeler-Kingshott, CA; Hawkins, C; Sharrack, B; Bastow, R; Weir, CJ; Stallard, N; Chandran, S; Gandini Wheeler-Kingshott, CAM; Williams, T; Beyene, T; Bassan, V; Zapata, A; Lyle, D; Cameron, J; Mollison, D; Colville, S; Dhillon, B; Gnanapavan, S; Nicholas, R; Rashid, W; Aram, J; Ford, H; Overell, J; Young, C; Arndt, H; Duddy, M; Guadagno, J; Evangelou, N; Craner, M; Palace, J; Hobart, J; Paling, D; Kalra, S; McLean, B

Lancet Neurol
O2, repositorio institucional de la UOC
Universitat Oberta de Catalunya (UOC)
Chataway, J, De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, MacManus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Giovannoni, G, Gandini Wheeler-Kingshott, C A, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J, Stallard, N, Chandran, S & MS-SMART Investigators 2020, 'Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART) : a phase 2b, multiarm, double-blind, randomised placebo-controlled trial', The Lancet Neurology, vol. 19, no. 3, pp. 214-225. https://doi.org/10.1016/S1474-4422(19)30485-5
Chataway, J, De Angelis, F, Connick, P, Parker, R A, Plantone, D, Doshi, A, John, N, Stutters, J, Macmanus, D, Prados Carrasco, F, Barkhof, F, Ourselin, S, Braisher, M, Ross, M, Cranswick, G, Pavitt, S H, Giovannoni, G, Gandini Wheeler-kingshott, C A, Hawkins, C, Sharrack, B, Bastow, R, Weir, C J & Stallard, N & Chandran, S 2020, ' Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART) : a phase 2b, multiarm, double-blind, randomised placebo-controlled trial ', The Lancet Neurology, vol. 19, no. 3, pp. 214-225 . https://doi.org/10.1016/S1474-4422(19)30485-5

Freedman, MS; Gnanapavan, S; Booth, RA; Calabresi, PA; Khalil, M; Kuhle, J; Lycke, J; Olsson, T

EBIOMEDICINE. 101:104970-104970

Dubuisson, N; Bauer, A; Buckley, M; Gilbert, R; Paterson, A; Marta, M; Gnanapavan, S; Turner, B; Baker, D; Giovannoni, G; Schmierer, K; Thomson, A

Multiple Sclerosis and Related Disorders. 17:172-176

Kuhle, J; Nourbakhsh, B; Grant, D; Morant, S; Barro, C; Yaldizli, O; Pelletier, D; Giovannoni, G; Waubant, E; Gnanapavan, S

Neurology. 88:826-831

Raftopoulos R; University College London Institute of Neurology, London, UK.; Kuhle J; Department of Neurology, University Hospital Basel, Basel, Switzerland.; Grant D; University College London Institute of Neurology, London, UK.; Hickman SJ; Department of Neurology, Royal Hallamshire Hospital, Sheffield, UK.; Altmann DR; Medical Statistics Department, London School of Hygiene & Tropical Medicine, London, UK.; Leppert D; Department of Neurology, University Hospital Basel, Basel, Switzerland.; Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Kapoor R; University College London Institute of Neurology, London, UK.; Giovannoni G; Department of Neuroscience & Trauma, QMUL, London, UK.; Gnanapavan S; Department of Neuroscience & Trauma, QMUL, London, UK.

Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE

Dubuisson N; Faculty of Medicine and Dentistry, Blizard Institute (Neuroscience), Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Neuromuscular Reference Center, Department of Neurology, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, Brussels 1200, Belgium. Electronic address: Nicolas.j.dubuisson@uclouvain.be.; de Maere d'Aertrijcke O; Department of Anesthesia and Perioperative Medicine, Cliniques Universitaires Saint-Luc, St Luc Hospital, Avenue Hippocrate 10, Brussels 1200, Belgium.; Marta M; Faculty of Medicine and Dentistry, Blizard Institute (Neuroscience), Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Gnanapavan S; Faculty of Medicine and Dentistry, Blizard Institute (Neuroscience), Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Turner B; Faculty of Medicine and Dentistry, Blizard Institute (Neuroscience), Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Baker D; Faculty of Medicine and Dentistry, Blizard Institute (Neuroscience), Queen Mary University London, 4 Newark Street, London E1 2AT, UK.; Schmierer K; Faculty of Medicine and Dentistry, Blizard Institute (Neuroscience), Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Giovannoni G; Faculty of Medicine and Dentistry, Blizard Institute (Neuroscience), Queen Mary University London, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Verma V; Department of Anesthesia, Royal London Hospital, Barts Health NHS Trust, London, UK.; Docquier MA; Department of Anesthesia and Perioperative Medicine, Cliniques Universitaires Saint-Luc, St Luc Hospital, Avenue Hippocrate 10, Brussels 1200, Belgium.

Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

Giovannoni, G; Marta, M; Davis, A; Turner, B; Gnanapavan, S; Schmierer, K

Practical Neurology. 16:389-393

Mahler, C; Andrews, M; Henson, SM; Gnanapavan, S

Neurol Neuroimmunol Neuroinflamm

Gnanapavan, S; Ho, P; Heywood, W; Jackson, S; Grant, D; Rantell, K; Keir, G; Mills, K; Steinman, L; Giovannoni, G

J Neurochem

Giovannoni, G; Turner, B; Gnanapavan, S; Offiah, C; Schmierer, K; Marta, M

Multiple Sclerosis and Related Disorders. 4:329-333

Gnanapavan, S; Sillery, E; Acheson, JF; Toosy, AT

Multiple Sclerosis and Related Disorders. 3:398-401

Keddie S; Emergency Care and Acute Medicine Clinical Academic Group, Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London.; National Hospital for Neurology and Neurosurgery, MRC Centre for Neuromuscular Diseases and Department of Molecular Neuroscience, University College London Hospitals NHS Foundation Trust, London.; Bharambe V; The Walton Centre NHS Foundation Trust, Liverpool.; Jayakumar A; Division of Infection, The Royal London Hospital, Barts Health NHS Trust, London, UK.; Shah A; Emergency Care and Acute Medicine Clinical Academic Group, Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London.; Sanchez V; Emergency Care and Acute Medicine Clinical Academic Group, Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London.; Adams A; Emergency Care and Acute Medicine Clinical Academic Group, Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London.; Gnanapavan S; Emergency Care and Acute Medicine Clinical Academic Group, Neuroscience, The Royal London Hospital, Barts Health NHS Trust, London.; The Walton Centre NHS Foundation Trust, Liverpool.

Publisher: Wiley Country of Publication: England NLM ID: 9506311 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-1331 (Electronic) Linking ISSN: 13515101 NLM ISO Abbreviation: Eur J Neurol Subsets: MEDLINE

Smets, I; Holden, D; Bianchi, L; Ammoscato, F; Allen-Philbey, K; Baker, D; Turner, B; Marta, M; Giovannoni, G; Macdougall, A; Schmierer, K; Hobart, J; Gnanapavan, S

Multiple Sclerosis and Related Disorders. 57:103409

Allen-Philbey K; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Stennett A; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, UK.; Begum T; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Johnson AC; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; MacDougall A; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, UK.; Green S; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Dobson R; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, UK.; Giovannoni G; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK; Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, UK.; Gnanapavan S; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Marta M; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Smets I; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Turner BP; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Baker D; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, 4 Newark Street, London E1 2AT, UK.; Mathews J; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK.; Schmierer K; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, 4 Newark Street, London E1 2AT, UK; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: k.schmierer@qmul.ac.uk.

Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

Lee, PR; Johnson, TP; Gnanapavan, S; Giovannoni, G; Wang, T; Steiner, JP; Medynets, M; Vaal, MJ; Gartner, V; Nath, A

J Neuroinflammation
Journal of Neuroinflammation, Vol 14, Iss 1, Pp 1-18 (2017)

Allen-Philbey K; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.; Stennett A; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.; Begum T; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.; Johnson AC; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.; Dobson R; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom.; Giovannoni G; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom.; Gnanapavan S; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.; Marta M; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.; Smets I; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.; Turner BP; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.; Baker D; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom.; Mathews J; Pharmacy, The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom.; Schmierer K; The Blizard Institute, Centre for Neuroscience, Surgery & Trauma, Queen Mary University of London, Barts and The London School of Medicine & Dentistry, London, United Kingdom; Clinical Board Medicine (Neuroscience), The Royal London Hospital, Barts Health NHS Trust, London, United Kingdom. Electronic address: k.schmierer@qmul.ac.uk.

Publisher: Elsevier B. V Country of Publication: Netherlands NLM ID: 101580247 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-0356 (Electronic) Linking ISSN: 22110348 NLM ISO Abbreviation: Mult Scler Relat Disord Subsets: MEDLINE

Gnanapavan, S; Giovannoni, G

Current Topics in Behavioral Neurosciences ISBN: 9783319255415

Dubuisson, N; Baker, D; Thomson, A; Marta, M; Gnanapavan, S; Turner, B; Giovannoni, G; Schmierer, K

Multiple Sclerosis Journal. 23:1956-1957

Gnanapavan, S; Kola, B; Bustin, SA; Morris, DG; McGee, P; Fairclough, P; Bhattacharya, S; Carpenter, R; Grossman, AB; Korbonits, M

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM; JUN 2002, 87 6, p2988-p2991, 4p.